Board meeting on 9 July to consider Rs 50 Cr Rights Issue

Bacil Pharma's Board will meet on 9 July 2026 to consider raising up to Rs 50 Crores through a Rights Issue of equity shares to eligible shareholders. Other agenda items include a possible increase in Authorised Share Capital, altering the Capital Clause of the Memorandum of Association, finalising terms of the Rights Issue such as entitlement ratio, issue price, and record date, and discussing director appointments and resignations. The trading window remains closed until 48 hours after the board meeting outcome is declared.